Biotest AG (ETR:BIO) | Finanzwire

Basculer en Français

10597	Companies
224782	Keywords
153520	Articles
118943	Press releases

Home
Companies
Biotest AG

PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 3 months ago

Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply

Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF

published on 02/28/2024 at 10:00, 2 years 3 months ago

Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne

Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE

published on 02/14/2024 at 08:30, 2 years 4 months ago

Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential

Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE

published on 11/28/2023 at 09:00, 2 years 6 months ago

EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE

published on 11/02/2023 at 08:00, 2 years 7 months ago

Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE

published on 10/05/2023 at 16:55, 2 years 8 months ago

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE

published on 10/05/2023 at 16:42, 2 years 8 months ago

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE

published on 09/21/2023 at 09:00, 2 years 8 months ago

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE

published on 09/12/2023 at 09:00, 2 years 9 months ago

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE

published on 09/07/2023 at 09:00, 2 years 9 months ago

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo

Accesswire

Published on 06/18/2026 at 18:00, 3 hours 36 minutes ago

BEACN Closes Second Series Under Loan Program and Previews BEACN App Version 1.4
Published on 06/18/2026 at 17:30, 4 hours 6 minutes ago

Sekur Private Data Appoints Nathan R. Price as Special Advisor for Diplomacy & Intelligence
Published on 06/18/2026 at 15:50, 5 hours 46 minutes ago

Pentagon I Capital Corp. and Prospectiva Resources Ltd. Announce Financing
Published on 06/18/2026 at 15:00, 6 hours 36 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 7 hours 6 minutes ago

Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 18:55, 2 hours 41 minutes ago

Holding(s) in Company
Published on 06/18/2026 at 18:55, 2 hours 41 minutes ago

Holding(s) in Company
Published on 06/18/2026 at 18:30, 3 hours 6 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/18/2026 at 18:25, 3 hours 11 minutes ago

Sopra Steria achives Level 2 Responsible Digital Label and strengthens its responsible digital strategy
Published on 06/18/2026 at 17:45, 3 hours 51 minutes ago

2CRSi SA: 2CRSi disputes the content of the document published by Grizzly Research and is preparing a substantiated response calling for the suspension of trading in its shares

Les Echos

Published on 06/18/2026 at 18:00, 3 hours 36 minutes ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 3 hours 51 minutes ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 3 hours 58 minutes ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 13:00, 8 hours 36 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 12 hours 30 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany

View all LES ECHOS COMFI WIRE